Lavender Bina Cendikia Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Lavender Bina Cendikia Tbk. trades at Rp30 (market cap 30.9B, 2.96M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 10.1× Lavender Bina Cendikia Tbk.'s market cap, and Lavender Bina Cendikia Tbk. is more actively traded (2.96M versus 963.6K). Which is the better fit depends on your goals.
| BMBL | DGNS | |
|---|---|---|
Market Cap | 30.9B | 310.75B |
Volume | 2.96M | 963.6K |
Lot | 29.64K | 9.64K |
Turnover | 88.75M | 217.67M |
Average Price | 29.94 | 225.89 |
Value | 88.75M | 217.67M |
Indicative Equilibrium Price | 30 | 226 |
Indicative Equilibrium Volume | 1 | 1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Lavender Bina Cendikia Tbk ("Company") was established on November 27, 2013 based on theNotarial deed of Suparman Hasyim, S.H., No. 35. The Company started its commercial operations in2013. The ultimate beneficial owner of the Company is Galih Pandekar.
Read more on BMBL →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →